Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06654986

Muscle Anabolic Response to β2-adrenergic Stimulation With Increased Amino Acid Availability.

The Importance of Amino Acid Availability in Modulating the Muscle Anabolic Response to β2-adrenergic Stimulation.

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
36 (estimated)
Sponsor
University of Copenhagen · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

The purpose of the project is to investigate the effect of amino acid availability on the muscle anabolic response to beta2-adrenergic stimulation in young healthy men and women.

Conditions

Interventions

TypeNameDescription
DRUGSalmeterol + amino acid availabilityThe participants will be administered 200 µg salmeterol (8 puffs) from a MDI device and 40 g amino acid availability (clear whey in a shaker with water) daily during a 6-week intervention. Participants will be instructed to provide documentation of both the inhalation and the shaker intake via video.
DRUGSalmeterol + placeboThe participants will be administered 200 µg salmeterol (8 puffs) from a MDI device. Furthermore they will be administered 80 g placebo (carbo fuel in a shaker with water) daily during a 6-week intervention. Participants will be instructed to provide documentation of both the inhalation and the shaker intake via video.
DRUGPlacebo + placeboThe participants will be administered placebo (8 puffs) from a MDI device. Furthermore they will be administered 80 g placebo (carbo fuel in a shaker with water) daily during a 6-week intervention. Participants will be instructed to provide documentation of both the inhalation and the shaker intake via video.

Timeline

Start date
2024-10-31
Primary completion
2026-12-18
Completion
2026-12-18
First posted
2024-10-23
Last updated
2025-04-09

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT06654986. Inclusion in this directory is not an endorsement.